EP3430384A4 - AUTOMATED METHOD FOR EVALUATING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREOF - Google Patents

AUTOMATED METHOD FOR EVALUATING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREOF Download PDF

Info

Publication number
EP3430384A4
EP3430384A4 EP17765612.1A EP17765612A EP3430384A4 EP 3430384 A4 EP3430384 A4 EP 3430384A4 EP 17765612 A EP17765612 A EP 17765612A EP 3430384 A4 EP3430384 A4 EP 3430384A4
Authority
EP
European Patent Office
Prior art keywords
tissue samples
automated method
cancer risk
evaluating cancer
evaluating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17765612.1A
Other languages
German (de)
French (fr)
Other versions
EP3430384A1 (en
Inventor
Ying Gu
Jason T.K. HWANG
Kenneth P.H. PRITZKER
Ranju Ralhan
Mi SHEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteocyte Diagnostics Inc
Original Assignee
Proteocyte Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteocyte Diagnostics Inc filed Critical Proteocyte Diagnostics Inc
Publication of EP3430384A1 publication Critical patent/EP3430384A1/en
Publication of EP3430384A4 publication Critical patent/EP3430384A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/60—Analysis of geometric attributes
    • G06T7/62—Analysis of geometric attributes of area, perimeter, diameter or volume
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10024—Color image
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30024—Cell structures in vitro; Tissue sections in vitro

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Quality & Reliability (AREA)
  • Microbiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Food Science & Technology (AREA)
  • Geometry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP17765612.1A 2016-03-14 2017-03-14 AUTOMATED METHOD FOR EVALUATING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREOF Pending EP3430384A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662308182P 2016-03-14 2016-03-14
PCT/CA2017/050333 WO2017156627A1 (en) 2016-03-14 2017-03-14 Automated method for assessing cancer risk using tissue samples, and system therefor

Publications (2)

Publication Number Publication Date
EP3430384A1 EP3430384A1 (en) 2019-01-23
EP3430384A4 true EP3430384A4 (en) 2019-07-31

Family

ID=59851352

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17765612.1A Pending EP3430384A4 (en) 2016-03-14 2017-03-14 AUTOMATED METHOD FOR EVALUATING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREOF

Country Status (2)

Country Link
EP (1) EP3430384A4 (en)
WO (1) WO2017156627A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060063190A1 (en) * 2004-09-22 2006-03-23 Tripath Imaging, Inc Methods and compositions for evaluating breast cancer prognosis
WO2007059629A1 (en) * 2005-11-25 2007-05-31 British Columbia Cancer Agency Branch Apparatus and methods for automated assessment of tissue pathology
CA2830501A1 (en) * 2011-03-17 2012-09-20 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
CA2904441A1 (en) * 2013-03-15 2014-09-18 Metamark Genetics, Inc. Compositions and methods for cancer prognosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011248632B2 (en) * 2010-04-27 2015-07-02 Prelude Corporation Cancer biomarkers and methods of use thereof
US10983126B2 (en) * 2013-05-31 2021-04-20 The Brigham And Women's Hospital System and method for analyzing tissue for the presence of cancer using bio-marker profiles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060063190A1 (en) * 2004-09-22 2006-03-23 Tripath Imaging, Inc Methods and compositions for evaluating breast cancer prognosis
WO2007059629A1 (en) * 2005-11-25 2007-05-31 British Columbia Cancer Agency Branch Apparatus and methods for automated assessment of tissue pathology
CA2830501A1 (en) * 2011-03-17 2012-09-20 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
CA2904441A1 (en) * 2013-03-15 2014-09-18 Metamark Genetics, Inc. Compositions and methods for cancer prognosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RALHAN R. ET AL: "Early Detection of Oral Lesions with Dysplasia at High-Risk of Cancer Development Using a Proteomic Signature Image Analysis Based StraticyteTM", GLOBAL ORAL CANCER FORUM 2016 (POSTER), 4 March 2016 (2016-03-04), XP055798963, Retrieved from the Internet <URL:http://www.globaloralcancerforum.org/img/Poster-Ralhan.pdf> *
See also references of WO2017156627A1 *

Also Published As

Publication number Publication date
WO2017156627A1 (en) 2017-09-21
EP3430384A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
EP3403895A4 (en) PARKING AID SYSTEM, PARKING AID METHOD, AND PROGRAM
EP3547207A4 (en) BLOOD VESSEL EXTRACTION METHOD AND SYSTEM
EP3413221A4 (en) METHOD AND SYSTEM FOR RISK ASSESSMENT
EP3488248A4 (en) AUTOMATED CLINICAL ANALYZER SYSTEM AND METHOD
EP3326528A4 (en) METHOD AND SYSTEM FOR ANALYZING THE APPROACH
EP3419543A4 (en) SYSTEM AND METHOD FOR AVOIDING COLLISION USING VIRTUAL LIMITS
EP3318978A4 (en) SYSTEM AND METHOD FOR SEMANTIC SPEECH ANALYSIS
EP3453148A4 (en) SYSTEM AND METHOD FOR LATENCY-BASED WAITING
EP3335440A4 (en) SYSTEM AND METHOD FOR LOCATION DETERMINATION USING MESH ROUTING
EP3482678A4 (en) PHYSIOLOGICAL CONDITION EVALUATION DEVICE, PHYSIOLOGICAL CONDITION EVALUATION METHOD, PROGRAM FOR PHYSIOLOGICAL CONDITION EVALUATION DEVICE AND PHYSIOLOGICAL CONDITION EVALUATION SYSTEM
EP3308308A4 (en) METHOD AND SYSTEM FOR IDENTIFYING AND MONITORING A PATIENT AND A BIOLOGICAL SAMPLE
EP3294112A4 (en) APPARATUS, SYSTEM AND METHOD FOR DETERMINING A PUPILLARY DISTANCE
EP3452825A4 (en) SYSTEM AND METHOD FOR DISTINGUISHING BLOOD COMPONENTS
EP3762851A4 (en) AUTOMATED SAFETY TEST SYSTEM AND PROCESS
EP3487792A4 (en) METHOD AND SYSTEM FOR EXECUTING COMMANDS WITH ADMISSION SORTING
EP3487435A4 (en) AUTOMATED EPILATION SYSTEM AND METHOD
EP3451278A4 (en) SYSTEM AND METHOD FOR CREATING DELIVERY PLAN
EP3690430A4 (en) SPECIFIC TEST ASSISTANCE SYSTEM AND METHOD AND SPECIFIC TEST ASSISTANCE PROGRAM
EP3328599A4 (en) METHOD AND SYSTEM FOR SAMPLING SEEDS
EP3441113A4 (en) TRANSCRANIAL MAGNETIC STIMULATION SYSTEM, POSITIONING ASSISTANCE METHOD, AND PROGRAM
EP3471658A4 (en) SYSTEM AND METHOD FOR JOINING MAXIMUM INTERCUSPIDATION
EP3407464A4 (en) MODEL IDENTIFICATION SYSTEM, MODEL IDENTIFICATION METHOD, AND MODEL IDENTIFICATION PROGRAM
EP3434552A4 (en) INSPECTION SYSTEM, INSPECTION METHOD AND PROGRAM
EP3792189A4 (en) SAMPLING METHOD AND SAMPLING SYSTEM
EP3460478A4 (en) BLOOD SAMPLE ANALYSIS METHOD AND SYSTEM FOR DETERMINING DIABETES

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190702

RIC1 Information provided on ipc code assigned before grant

Ipc: G06T 7/00 20170101AFI20190626BHEP

Ipc: G01N 21/84 20060101ALI20190626BHEP

Ipc: G01N 33/574 20060101ALI20190626BHEP

Ipc: G01N 15/02 20060101ALI20190626BHEP

Ipc: G06T 7/62 20170101ALI20190626BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210507